KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $3.8 million.

  • CareDx's Depreciation & Amortization (CF) rose 994.52% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.5 million, marking a year-over-year increase of 22.82%. This contributed to the annual value of $14.2 million for FY2024, which is 133.46% down from last year.
  • Latest data reveals that CareDx reported Depreciation & Amortization (CF) of $3.8 million as of Q3 2025, which was up 994.52% from $3.7 million recorded in Q2 2025.
  • In the past 5 years, CareDx's Depreciation & Amortization (CF) ranged from a high of $3.8 million in Q1 2024 and a low of $2.0 million during Q1 2021
  • Over the past 5 years, CareDx's median Depreciation & Amortization (CF) value was $3.4 million (recorded in 2023), while the average stood at $3.2 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first soared by 3760.8% in 2022, then crashed by 743.6% in 2024.
  • Quarter analysis of 5 years shows CareDx's Depreciation & Amortization (CF) stood at $2.5 million in 2021, then increased by 28.45% to $3.2 million in 2022, then rose by 13.26% to $3.6 million in 2023, then decreased by 7.44% to $3.4 million in 2024, then rose by 13.48% to $3.8 million in 2025.
  • Its last three reported values are $3.8 million in Q3 2025, $3.7 million for Q2 2025, and $3.6 million during Q1 2025.